A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Neogen Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 17,260 shares of NEOG stock, worth $260,280. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,260
Previous 19,679 12.29%
Holding current value
$260,280
Previous $396,000 31.31%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

SELL
$15.0 - $20.35 $36,285 - $49,226
-2,419 Reduced 12.29%
17,260 $272,000
Q4 2023

Feb 09, 2024

SELL
$14.65 - $20.7 $418,814 - $591,771
-28,588 Reduced 59.23%
19,679 $396,000
Q3 2023

Oct 24, 2023

SELL
$18.4 - $23.84 $50,176 - $65,011
-2,727 Reduced 5.35%
48,267 $895,000
Q2 2023

Jul 13, 2023

SELL
$16.1 - $21.95 $25,148 - $34,285
-1,562 Reduced 2.97%
50,994 $1.11 Million
Q1 2023

May 11, 2023

SELL
$15.26 - $21.41 $59,101 - $82,920
-3,873 Reduced 6.86%
52,556 $973,000
Q4 2022

Feb 08, 2023

BUY
$10.79 - $16.56 $14,588 - $22,389
1,352 Added 2.45%
56,429 $859,000
Q3 2022

Oct 17, 2022

BUY
$13.97 - $24.33 $21,150 - $36,835
1,514 Added 2.83%
55,077 $769,000
Q2 2022

Jul 13, 2022

SELL
$22.65 - $31.52 $29,694 - $41,322
-1,311 Reduced 2.39%
53,563 $1.29 Million
Q1 2022

May 12, 2022

SELL
$30.84 - $44.37 $181,246 - $260,762
-5,877 Reduced 9.67%
54,874 $1.69 Million
Q4 2021

Feb 03, 2022

SELL
$39.35 - $46.65 $34,470 - $40,865
-876 Reduced 1.42%
60,751 $2.76 Million
Q3 2021

Nov 02, 2021

SELL
$40.16 - $46.19 $72,970 - $83,927
-1,817 Reduced 2.86%
61,627 $2.68 Million
Q2 2021

Aug 10, 2021

BUY
$44.24 - $48.33 $1.46 Million - $1.59 Million
32,934 Added 107.94%
63,444 $2.92 Million
Q1 2021

May 07, 2021

SELL
$38.85 - $44.45 $18,065 - $20,669
-465 Reduced 1.5%
30,510 $1.36 Million
Q4 2020

Feb 04, 2021

BUY
$34.15 - $40.93 $21,856 - $26,195
640 Added 2.11%
30,975 $1.23 Million
Q3 2020

Oct 29, 2020

BUY
$36.62 - $40.95 $41,600 - $46,519
1,136 Added 3.89%
30,335 $1.19 Million
Q2 2020

Jul 27, 2020

BUY
$30.51 - $38.8 $41,890 - $53,272
1,373 Added 4.93%
29,199 $1.13 Million
Q1 2020

May 08, 2020

BUY
$27.01 - $36.38 $66,525 - $89,603
2,463 Added 9.71%
27,826 $931,000
Q4 2019

Feb 04, 2020

SELL
$31.33 - $34.86 $13,221 - $14,710
-422 Reduced 1.64%
25,363 $827,000
Q3 2019

Nov 06, 2019

SELL
$30.12 - $39.4 $1,114 - $1,457
-37 Reduced 0.14%
25,785 $877,000
Q2 2019

Aug 15, 2019

BUY
$27.41 - $31.64 $7,400 - $8,542
270 Added 1.06%
25,822 $0
Q1 2019

May 08, 2019

BUY
$27.08 - $31.99 $4,061 - $4,798
150 Added 0.59%
25,552 $0
Q4 2018

Feb 05, 2019

SELL
$26.36 - $35.12 $176,084 - $234,601
-6,680 Reduced 20.82%
25,402 $723,000
Q3 2018

Nov 02, 2018

BUY
$35.25 - $48.25 $104,058 - $142,434
2,952 Added 10.13%
32,082 $0
Q2 2018

Aug 10, 2018

BUY
$32.76 - $41.85 $25,421 - $32,475
776 Added 2.74%
29,130 $0
Q1 2018

May 09, 2018

BUY
$27.32 - $33.49 $186,978 - $229,205
6,844 Added 31.82%
28,354 $0
Q4 2017

Feb 22, 2018

SELL
$28.83 - $31.62 $122,642 - $134,511
-4,254 Reduced 16.51%
21,510 $0
Q3 2017

Nov 07, 2017

BUY
$24.46 - $29.05 $27,126 - $32,216
1,109 Added 4.5%
25,764 $2 Million
Q2 2017

Aug 08, 2017

BUY
N/A
24,655
24,655 $1.7 Million

Others Institutions Holding NEOG

About NEOGEN CORP


  • Ticker NEOG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 216,108,000
  • Market Cap $3.26B
  • Description
  • Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal f...
More about NEOG
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.